# GONO GI Foundation

> A group of experts promoting independent research in the field of clinical oncology in Italy

Generated by Yoast SEO v28.3, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Homepage](https://fondazionegono-gi.org/)
- [Publications](https://fondazionegono-gi.org/publications/)
- [About us](https://fondazionegono-gi.org/about-us/)
- [Filippo Pietrantonio](https://fondazionegono-gi.org/team/filippo-pietrantonio/)
- [Lorenzo Fornaro](https://fondazionegono-gi.org/team/lorenzo-fornaro/)

## Posts
- [AACR Annual Meeting 2026](https://fondazionegono-gi.org/international-meetings/aacr-annual-meeting-2026/)
- [ESMO GI Congress 2026](https://fondazionegono-gi.org/international-meetings/esmo-gi-congress-2026/): Read GONO studies presented at the 2026 ASCO Annual Meeting\.
- [2026 ASCO Annual Meeting](https://fondazionegono-gi.org/international-meetings/asco-annual-meeting-2026/): Take a look at the GONO studies presented during the 2026 ASCO Annual Meeting in Chicago\.
- [ESMO Congress 2025](https://fondazionegono-gi.org/international-meetings/esmo-congress-2025/): Read GONO studies presented at the 2025 ESMO Congress\.
- [ESMO GI Congress 2025](https://fondazionegono-gi.org/international-meetings/esmo-gi-congress-2025/): Read GONO studies presented at the 2025 ASCO Annual Meeting

## Ongoing\-projects
- [ESSEUNO](https://fondazionegono-gi.org/ongoing-projects/esseuno/): S\-1 Real\-World is a prospective, observational, multicenter real\-world study on the use of S\-1 for patients with metastatic colorectal cancer \(mCRC\) after previous intolerance to 5\-fluorouracil or capecitabine\.
- [Fruit](https://fondazionegono-gi.org/ongoing-projects/fruit/): Fruit is an observational, multicenter, retrospective and prospective Real\-World Study on the use of Fruquintinib for patients with metastatic Colorectal Cancer who progressed after standard therapy\.
- [ShorTRIP](https://fondazionegono-gi.org/ongoing-projects/shortrip/): The standard treatment for locally advanced rectal cancer \(LARC\) patients is based on neoadjuvant chemo\-radiation or short\-course radiotherapy followed by TME surgery\.
- [INFINITY](https://fondazionegono-gi.org/ongoing-projects/infinity/): INFINITY is a Phase II, multicentre, single\-arm, multi\-cohort trial aimed at evaluating the activity and safety of the combination of tremelimumab and durvalumab as neoadjuvant \(Cohort 1\) and definitive \(Cohort 2\) treatment for gastric/gastroesophageal juction cancer patients\.
- [Mercury](https://fondazionegono-gi.org/ongoing-projects/mercury/): The Merkel cell carcinoma \(MCC\) is an extremely rare cutaneous epithelial malignancy with highly aggressive behavior\.

## Optional
- [Sitemap index](https://fondazionegono-gi.org/sitemap_index.xml)